At Allogene, our mission is to create the next revolution in cancer treatment by advancing allogeneic CAR T therapies, or AlloCARs™, directed at blood cancers and solid tumors. With this goal, we are setting out to do something that has never been done before. We recognize that it won’t be easy and will require a lot of hard work, expertise, and dedication. As a team working together, we believe we can make allogeneic CAR T cell therapy a reality for patients and change how cancer is treated.
- We have an experienced, high-performance and growing team of employees whose sole focus is to transform the treatment of cancer.
- We have a deep pipeline of innovative AlloCARs™.
- We have an allogeneic platform based on validated gene editing and advanced proprietary cell manufacturing technologies.
- We are on our way to building a culture and a company focused on working collaboratively to do something big for cancer patients.
Our four values – Focus, Innovate, Collaborate and Lead – are core to our organization and how we conduct ourselves every day.
We are focused on AlloCAR T therapy, our mission and our commitment to patients.
We are rooted in science and innovative in our approach to finding better solutions for treating cancer.
We are one team collaborating toward one vision.
We have the expertise and courage to take calculated risks in order to lead the next revolution in the treatment of cancer.